Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 16.861\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CCOc1ccc(/C=N/OCC(=O)Nc2ccc3c(c2)OCO3)cc1
b. C/C(Cn1cnc([N+](=O)[O-])n1)=N\NC(=O)c1ccncc1
c. O=c1cc(Cc2ccccc2)[nH]c(=S)[nH]1
d. CCC(C)(C)NC(=O)CCCSc1nc2ccccc2s1
Answer: d. CCC(C)(C)NC(=O)CCCSc1nc2ccccc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)CCCSc1nc2ccccc2s1
CCC(C)(C)NC(=O)CCCSc1nc2ccccc2s1
4-(1,3-benzothiazol-2-ylsulfanyl)-N-(2-methylbutan-2-yl)butanamide